Market Overview

Goldman Sachs Bearish On Standalone Rite Aid

Goldman Sachs Bearish On Standalone Rite Aid
Related RAD
10 Stocks To Watch For September 27, 2018
Earnings Scheduled For September 27, 2018

After a failed merger with Walgreens Boots Alliance Inc (NASDAQ: WBA) and the termination of a merger agreement with Albertsons, one Wall Street analyst says Rite Aid Corporation (NYSE: RAD) is now in an extremely difficult competitive position and will likely continue to struggle in the market.

The Analyst

Goldman Sachs analyst Robert Jones resumed coverage of Rite Aid with a Sell rating and $1 price target.

The Thesis

A standalone Rite Aid simply doesn’t have the resources to effectively compete, Jones said.

“We expect RAD’s smaller footprint will hamper it from participating in the continued growth of preferred/narrow networks in Part D and commercial plans, where store breadth is essential to getting in network and pricing competitively,” Jones wrote in a note.

He said this trend has already been playing out in recent years. Since 2013 Rite Aid’s same-store prescription growth has been roughly flat. In that same time, Walgreens and CVS Health Corp (NYSE: CVS) have been growing same-store prescriptions by 4.5 percent and 3.9 percent, respectively.

The only silver lining for Rite Aid investors is that the stock trades at a slight forward EV/EBITDA multiple discount to its peers. However, Jones said that discount is justified given Rite Aid’s relatively weak revenue and margin growth profile.

For now, Goldman doesn’t see a light at the end of the tunnel. Jones said EBITDA declines have continued since Rite Aid’s asset sales in late 2017 and he sees no indication that trend will reverse any time soon.

Price Action

Rite Aid traded lower by 4 percent Thursday to $1.30 per share.

Related Links:

M&Ain't: Several Of The Year's Biggest Mergers Face Uncertain Future

Two Major Mergers Fall Through, A Reminder That Deals Don't Always Work Out

Photo credit: Mike Mozart, Flickr

Latest Ratings for RAD

Sep 2018Goldman SachsReinstatesSell
Aug 2018Cowen & Co.DowngradesOutperformMarket Perform
Jan 2018Evercore ISI GroupInitiates Coverage OnUnderperform

View More Analyst Ratings for RAD
View the Latest Analyst Ratings

Posted-In: Goldman Sachs Robert JonesAnalyst Color Price Target Initiation Analyst Ratings Best of Benzinga


Related Articles (CVS + RAD)

View Comments and Join the Discussion!

Latest Ratings

DESPKeyBancInitiates Coverage On0.0
MELIKeyBancInitiates Coverage On0.0
ABTCredit SuisseInitiates Coverage On82.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

The Upwork IPO: What You Need To Know

Credit Suisse Joins Consensus To Prescribe Sarepta